Phase II Clinical Study to Assess the Efficacy and Safety of Nemonoxacin Malate in Treating Adult Patients With Community-acquired Pneumonia (CAP)
Clinical trial NCT01537250 · COMPLETED
Trial details
- NCT number
- NCT01537250
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2010-08-01
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.